Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 184 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

 		Glomerulonephritis, IGA, Immunoglobulin A Nephropathy Phase2 Malaysia
United States 		NCT06797518

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

 		Chronic Spontaneous Urticaria (CSU) Phase3 United States NCT06868212

A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

 		Prostatic Cancer, Castration-Resistant Phase2 Singapore NCT07047118

A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

 		Difficult-to-treat Rheumatoid Arthritis (RA) and Severe, Refractory Sjögren's Disease (SjD) Phase1, Phase2 Singapore NCT07048197

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

 		Rheumatoid Arthritis Phase1 China NCT07029555

Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

 		Atherosclerotic Cardiovascular Disease Russian Federation NCT06858332

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

 		Atherosclerotic Vascular Disease, Heterozygous Familial Hypercholesterolemia Spain NCT06958315

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

 		Atherosclerotic Cardiovascular Disease (ASCVD) Phase3 United States NCT06813911

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

 		Hematologic Malignancy, Solid Tumor, Advanced Malignancies Phase3 Belgium
Italy
Netherlands
United Kingdom
United States
View All
 NCT06401356

Home Reported Outcomes in C3G Study

 		C3 Glomerulopathy United States NCT07029542